Zynex Inc (NASDAQ:ZYXI) COO Anna Lucsok shared insights earlier this week about the company’s operational strategies and future growth plans in an interview with Proactive.
Lucsok discussed the company’s strong performance in sales and reimbursement, as well as its mission to provide non-opioid pain management solutions.
The COO highlighted that Zynex's reimbursement department has been a significant factor in the company’s success. The company accepts all insurance types, navigating a complex array of carriers to help secure patient coverage.
"Our reimbursement team has been very successful at identifying how to secure coverage for our patients," Lucsok said.
On the sales front, Zynex has achieved productivity gains, with performance per sales representative doubling compared to two years ago. The company plans to expand its sales force while focusing on maintaining high productivity levels.
Looking ahead, Zynex intends to broaden its product range, aiming to become a household name for non-opioid pain management solutions. The company offers a variety of products, including electrotherapy, bracing, cervical traction, and hot and cold therapy.
Lucsok indicated that Zynex is well-positioned for growth. "We have a really bright future ahead,” she said.
Investors may watch the company’s continued expansion and the introduction of new products as potential catalysts for future performance.